A Comprehensive Review On: Polycystic Ovarian Disease and It’s Impact on Health Care of Female
DOI:
https://doi.org/10.63682/jns.v14i5S.7275Keywords:
PCOD, Androgen, Hirsutism, insulin resistance, morbiditesAbstract
Poly cystic ovarian disease (PCOD) is a complex pathophysiology and common endocrine, metabolic disorder that affect the ovaries and can lead to physiological, irregular menstrual cycle also the main reason of infertility and also formation of cysts in the ovary. It’s also know as Polycystric ovarian syndrome. PCOS is a hormonal condition that results in larger ovaries with little cysts around the periphery.This hormonal disorder globally affect the more then 5 - 15% ladies at their puberty age leading to decreasing the level of Oestrogen and Progesterone. They also have increasing the level of Androgen. This ovulation process stimulated by bodily hormone. The clear root of PCOS it’s genetic alliance and hormonal disbalance with most usual manifestation , acne on face, hirsutism, insulin resistance, hair loss, obesity. The acumen regarding management of PCOD through healthy life style with physical activity like Yoga. PCOS is considered focus on implement or modification in way of living style to the community (education, stop smoking, rational diet , not consumption of alcohol and weight management) when necessary are of the importance and early obstruction to fend off future morbidities.
Downloads
Metrics
References
Singh S et al “Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics” Journal of clinical medicine 2023; 12(14):1 - 24
Ganie M A et al “Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India” Indian Journal of Medical Research 2019; (10) :333- 344
Shahebrahimi K et al “Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome” Indian Journal of Endocrinology and Metabolism 2016 ; 20 (6): 805- 809
Allahbadi G N et al “Polycystic ovary syndrome and impact on health” Middle East Fertility Society Journal 2011; 16: 19-37
Azziz R et al “Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span” The Journal of Clinical Endocrinology & Metabolism2005; 90(8):4650 – 4658
Costello M E et al “Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review” European Society of Human Reproduction and Embryology 2007;22(5):1200–1209
Hirsch K E et al “Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome” J Clin Endocrinol Metab.2008; 93(7):2670 –2678
Atay V et al “ Comparison of Letrozole and clomiphene citrate in women with Polycystics ovaries undergoing ovarian stimulation” The Journal of International Medical Research 2006; 34:73-76
Joshi B et al “ A cross- sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India” Indian Journal of Endocrinology and Metabolism 2014; Vol 18(3): 317-324
Johnstone E B et al “The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic Significance” J Clin Endocrinol Metab 2010, 95(11):4965– 4972
Chandrasekhar H et al “Awareness of Polycystic Ovarian Disease among Females of Age Group 30 – 50 Years” Journal of pharmaceutical science and research 2008; Vol 8(8): 817- 821
Shrestha A et al “Assessment of Lifestyle and Diet Modification of Patients Suffering from Polycystic Ovarian Disease (PCOD) in North India” Journal of Food and Nutrition Sciences 2019; 7(4): 60-65
Varghese R et al “Health related complications associated with polycystic ovarian disease (PCOD)” The Pharma Innovation Journal 2018; 7(11): 86-90
Collee J et al “Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments” , Gynecological Endocrinology 2021; 37(10): 869-874
Gandevani S B et al “The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis” Clinical Endocrinology 2018; 88:169–184.
Deswal R et al “The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review” Journal of Huamn Reproductive science 2020; 13(4): 261 -71
Amiri M et al “ Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression” Reproductive Biology and Endocrinology 2020;18(23):1- 15
Ding T et al “The prevalence of polycystic ovary syndrome in reproductiveaged women of different ethnicity: a systematic review and meta-analysis” Oncotarget2017; 8(56):96351-96358
Wekker V et al “Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis” Human Reproduction Update 2020; 26(6) : 942–960
Hoeger K M et al “Update on PCOS: Consequences, Challenges, and Guiding Treatment” The Journal of Clinical Endocrinology & Metabolism 2021; 06(3):1071–1083
Gharaghie T P et al “Polycystic ovary syndrome and genetic factors influencing its development: A review article” Personalized Medicine Journal 2021; 6(23) :25-29
Pandey A et al “A Review on Health Care Surveillance of PCOD” PriMera Scientific Medicine and Public Health 2023; 3(6) :4S-15
Robert L et al “The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited” Endocrine Reviews 2016; 37(5) :467–520
Akhter F D et al “Management of Adolescent PCOD: A Real Challenge” Scholars International Journal of Obstetrics and Gynecology 2024;7(2): 64-69
Thomas J E et al “Investigating the impact of lifestyle factors on PCOD: A comiprehensive analysis of BMI, Diet, Physical activity , Stress and family history” World Journal of Pharmaceutical Research 2024; 13(11) :1415-1425
Sirman S M et al “Epidemiology, diagnosis, and management of polycystic ovary syndrome” Clinical Epidemiology 2014;6 :1–13
Radha P et al “Comparative study of prevalence of polycystic ovarian syndrome in rural and urban population” Journal of Advance medical and dental sciences research 2016;4(2):90-95
Das Debajyoti et al “ Effect of Ayurvedic Medicine in Polycystic ovarian Disease (PCOD) : A Single case study” World journal of pharmaceutical research 2024;13(16): 760-767
Pena A S et al “Adolescent polycystic ovary syndrome according to the international evidence based guideline” BMC Medicine 2020;18(72):2-16
Ziaee A et al “Effect of metformin and pioglitazone treatment on cardiovascular risk profile in polycystic ovary syndrome” Acta Medica Indonesiana - The Indonesian Journal of Internal Medicine 2012;44(1): 16-22
Ajmal N et al “Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article”European journal of obstetrics & Gynecology and Reproductive biology 2019:3
Xu Y et al “Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature” Journal of Healthcare Engineering 2022: 1-13
Akre S et al “Recent Advances in the Management of Polycystic Ovary Syndrome: A Review Article” Cureus 2022;14(8): 2-6
Nicandri K F et al “Diagnosis and treatment of polycystic ovarian syndrome in adolescents”Reproductive endocrinology 2012 ;19(6):498-504
Mehar K “An Ayurvedic approach of the PCOD: A review article”World Journal of Pharmaceutical Research 2023;12(12):231-237
Mishra V et al “Ayurvedic review of PCOD and its management”European Journal of Pharmaceutical and Medical Research 2023;10(9) :239-243
Bashir A et al “Comprehension, Management, and Treatment of Polycystic Ovarian Syndrome via Allopathic, Unani and Ayurvedic Perspectives” Journal of Gynecology and Women’s Health 2021; 21(1): 001-009
Mirza S et al “Management of Polycystic Ovarian Syndrome (Keesa-e-Khusyatur Rehm): Unani Perspective” American journal of pharmacy and health research 2016; 4(1):24-26
Husain M T et al “Polycystic ovarian disease Management in Unani system of medicine” International Journal of advanced medicine 2023; 7(5):1-3
Masroor D et al “Comparative risk reduction of complications pertaining to polycystic ovarian syndrome by multiple treatment options” Pakistan Journal of Pharmaceutical Sciences 2022 ; 35(3) :807-813
Patel A et al “A Comprehensive Review on Treatments for Polycystic Ovarian Syndrome” Nursing & Primary Care 2024;8(1):1-17
Tsilchorozidou T et al “The pathophysiology of polycystic ovary syndrome” Clinical Endocrinology 2004; 60:1–17
Begum G S et al “Assessment of Risk Factors for development of Polycystic Ovarian Syndrome” International Journal 0f Contemporary medical research 2017; 4(1):164-167
Anjali C S et al “PCOD in female reproductive age -A review” World journal of pharmaceutical research 2020;9(1):677-684
Merkin S S et al “Environmental determinants of polycystic ovary syndrome” Fertility and Sterility 2016;106 (1):16-24
Rocha A L et al “Recent advances in the understanding and management of polycystic ovary syndrome” F1000Research 2019;8:2- 11
Moran L J et al “Weight management practices associated with PCOS and their relationships with diet and physical activity” European Society of Human Reproduction and Embryology 2017;32(3):669-678
Smyka M et al “The role of lifestyle changes in the treatment of polycystic ovary syndrome” Neuroendocrinology Letters 2017;38(8):521-527
Murri M et al “Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis” Human Reproduction Update 2013;19(3):268–288
Spritzer P M “Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances” Arq Bras Endocrinol Metab 2014;58(2):182-187
Begum M S et al “Optimizing Polycystic Ovarian Disorder (PCOD) Treatment with Personalized Lifestyle and Nutrition Strategies” journal of clinical medical research 2023; 4(3):1-8
Chugani S et al “A study to Ascertain the role of homeopathy medicine in Treatment of Infertility in female” World journal of Pharmaceutical Reseach 2024;13(17):446-455
Prema S et al “Development and Evaluation of Polyherbal Phyto-phospholipid Complexes (Phytosomes) for PCOD Treatment” International Journal of Drug Delivery Technology 2024;14(2):853-857
Coffin T et al “A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students” Cureus 2023;15(6):1-16
Coffey S et al “The effect of polycystic ovary syndrome on health-related quality of life” Gynecological Endocrinology 2003; 17:379–386
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
